A recent study published in the peer-reviewed Journal of the American Medical Association (JAMA) shows promising results on use of the varenicline (generic Chantix) in adolescents and young adults who vape nicotine. When compared to placebo or behavioral counseling alone, participants taking varenicline had more than three times higher abstinence rates. Overall, varenicline was well tolerated, with only two participants leaving the study due to adverse effects.

The number of patients I’m seeing for help with e-cigarette use has gone up exponentially in the last few years.

Tobacco smoke is a common trigger for asthma attacks – both directly when inhaled and indirectly as secondhand smoke.